Our complementary MBA programmes in Biotechnology and in Life Sciences enable scientists to enter this growing industrial sector each year. We help our students develop a clear vision of their career progression into future leadership roles. By using the new skills and practical experiences from our courses, our alumni go on to join the some of the most notable institutions, companies and national healthcare systems with international reputations.
After successfully passing the all the required evaluations and approval of the final Thesis, Dissertation or Business Plan, which is evaluated by a panel of industry experts, the minimum requirements for the qualification will have been achieved. Under the current academic European standards, based on the required number of credits according to the European Credit Transfer and Accumulation System (ECTS), students will receive a certificate awarded by the Biotechnology Business Institute, which is an independent privately owned Business School focused on the education in biotechnology. The diploma or degree will depend on the specific course undertaken.
The Biotechnology Business Institute (BBI) is an international business school focused on training a new generation of scientific managers and executives to prepare for their future careers. The BBI facilitates early-stage business development activities in partnership with the many stakeholders in the biotechnology sector and the pharmaceutical industry worldwide. A core focus is on new drug development to treat unmet medical need but also with broadening interests across the Life Sciences sector.
The Biotechnology Business Institute was founded to develop the next generation of talent in the international Life Sciences sector for scientists seeking to advance their careers in the pharmaceutical and biotechnology industries. We are committed to becoming a leading international academic institution in the management of Life Sciences, through enabling the career development of a new wave of global business leaders driving disruptive change throughout the ecosystem.
The BBI Business School has over 140 academics and industry experts, coming from more than 20 countries, who cover the key management topics in the Life Sciences industry: corporate finance; market access and healthcare economics, preclinical and clinical regulatory requirements, medical technologies, technology transfer and entrepreneurship, organisational behaviour and an understanding of the global strategy for new drug approvals.
With a presence in two of the main innovation centres in Europe, Barcelona, and Cambridge, and the second largest market in the pharmaceutical industry in Latin America our students can choose which campus will best meet their needs.
As the International BBI headquarters, the Barcelona Campus is focused on drug discovery, built on a track record since 2013 delivering management programmes for scientists wanting to develop their careers in the global pharma & biotechnology industry.
The European headquarters, our Cambridge Campus, has a broader remit across the entire Life Science sector. At Cambridge, UK, our students can realise their objective of establishing a global network of contacts in the broader spectrum of commercial opportunities in Life Sciences.
Know more about our campuses
We have classes running in-person in our Barcelona campus with a number of additional safety measures in place to protect our students and staff. We have limited the class size to guarantee compliance with local health requirements. Also, it is possible for students to join remotely if they cannot join in person or are not feel they are unable to attend in person.
The Cambridge Campus will only deliver the eMBA in Life Sciences online for the time being. With new hybrid technology, our programmes remain an interactive opportunity for our students to learn.
Our Barcelona campus is open to visitors and classes are running, however under the local mandatory safety measures to ensure everyone’s safety. For the safety of our staff and participants, campus visits are limited and are subject to candidates’ interviews being completed. If you want to visit the campus, please to schedule a meeting.
The Cambridge Campus will only deliver the eMBA in Life Sciences online for the time being. At the moment, physical visits are not a possibility although the eMBA specialist are always available over email, phone or ready to schedule a meeting and solve any doubt you might have. Also, a number of MBA open days delivered online are scheduled for candidates to solve their questions. Contact us here and check our event site to apply for the online events.
Every day is different throughout the year. During the first stage, when students take their common modules, apart from the evening classes from Monday to Thursday, the students also develop their career impact programmes. These programmes have their project meetings at various research centres and participate in extra-curriculum activities.
For the final semester in Barcelona, each student develops their own academic internship programme depending on their chosen career itinerary chosen. All programmes have the same number of assignments and group work to complete. Typically, the second semester is focused increasing the time spent on students’ career-related activities.
Thanks to our unique educational agreement with three of the main research centres in Barcelona our model, based on a practical patent filings, that allows our students to have an intensive full-time experience to achieve a global understanding of commercial decision-making processes.
Discussions with principal researchers and innovation managers who are planning on developing new drugs make this experience very interactive and with the academic co-ordination and the board of lectures further discussion are continued during the practical classes. The case study case is a real example, reflecting today’s global business ecosystem in biotechnology and the pharmaceutical industry.
The BBI network is formed by our alumni, the academic staff, lecturers, partner companies and the technology transfer offices who collaborate with us. Over the years, we have developed a community over 700 people globally in direct contact every year.
For more information, visit our BBI community Report